MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog …

(NASDAQ:MIRA) (“MIRA” or the “Company”), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and …